Bonjesta

Bonjesta combines doxylamine succinate and pyridoxine hydrochloride for oral use. It is commonly used to manage nausea and vomiting during pregnancy. This medication is manufactured by Exeltis Germany GmbH and is available in the EU market.

Bonjesta is primarily used to alleviate nausea and vomiting associated with pregnancy. The combination of doxylamine succinate, an antihistamine, and pyridoxine hydrochloride, a form of vitamin B6, works together to provide relief. Many women find this medication helpful in managing morning sickness and other pregnancy-related discomforts.

Bonjesta may cause drowsiness, dizziness, or dry mouth in some individuals. These effects are generally mild and temporary. It is important to use this medication as directed to minimize potential side effects.

Bonjesta should be used with caution in individuals with certain medical conditions, such as asthma, glaucoma, or liver disease. It is important to consult a healthcare provider before starting this medication, especially if you are taking other medications or have pre-existing health conditions.

Bonjesta may interact with other medications, including sedatives, antidepressants, and certain pain relievers. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Additionally, alcohol should be avoided while using Bonjesta as it can enhance drowsiness.